Drug intelligence / Profile preview

Tian Jing Formula

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Tian Jing Formula is a Traditional Chinese Medicine (TCM) herbal formulation developed by Longhua Hospital at the Shanghai University of Traditional Chinese Medicine. It is specifically designed to treat premature ovarian insufficiency (POI) characterized by kidney deficiency, following the therapeutic principle of capitalizing the kidney and regulating the liver. The formula is intended to improve ovarian reserve function, enhance ovarian responsiveness to stimulation, and mitigate symptoms resulting from low estrogen levels. It is currently undergoing multicenter clinical evaluation to validate its efficacy and safety profile in restoring reproductive endocrine function in patients with POI.

Other names
Tianjing FormulaTianjing Fang
02

Targets

Histone deacetylase 3–Heat shock protein 90 alpha–Peroxisome proliferator-activated receptor gamma coactivator 1-alpha mitochondrial regulatory axisAMHR2 (Anti-Müllerian hormone receptor type 2)

Beyond the preview

Go deeper on Tian Jing Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tian Jing Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call